![](img/space.gif) |
The effect of adipocitokines on HDL level and function in atherosclerotic patients
|
Help
Print
|
Here you can view and search the projects funded by NKFI since 2004
Back »![](img/space.gif)
![](img/space.gif)
![](img/space.gif)
![](img/space.gif)
|
![](img/print_ver.gif) |
List of publications |
|
|
Peti A, Csiky B, Guth E, Kenyeres P, Varga Z, Seres I, Jeney Z, Juhasz M, Mezosi E, Paragh G, Kovacs GL, Bajnok L.: Associations of adiponectin with paraoxonase 1 and sE-selectin in hemodialyzed patients., Kidney Blood Press Res. 32(5):360-5., 2009 | Gy Paragh, I Seres, M Harangi, Zs Pocsai, L Asztalos, L Lőcsey, Gy Szeles, L Kardos, É Varga, I Kárpáti, R Ádány:: Discordance in human paraoxonase-1 gene between phenotypes and genotypes in chronic kidney disease., Nephron Clin Pract 113:c46-c53., 2009 | Varga E, Seres I, Harangi M, Sztanek F, Asztalos L, Lõcsey L, Borbás B, Szegedi J, Kárpáti I, Paragh G.: Serum cystatin C is a determinant of paraoxonase activity in hemodialyzed and renal transplanted patients., Dis Markers. 26(3):141-8, 2009 | Koncsos P, Seres I, Harangi M, Illyés I, Józsa L, Gönczi F, Bajnok L, Paragh G.: Human paraoxonase-1 activity in childhood obesity and its relation to leptin and adiponectin levels., Pediatr Res. 67(3):309-13, 2010 | Bajnok L, Csongradi E, Seres I, Varga Z, Jeges S, Peti A, Karanyi Z, Juhasz A, Mezosi E, Nagy EV, Paragh G.: Relationship of adiponectin to serum paraoxonase 1., Atherosclerosis. 197(1):363-7., 2008 | G. Paragh, M. Harangi, I. Seres: EFFECT OF LIPID LOWERING MEDICATIONS ON PON1, in: The Paraoxonases: Their Role in Disease Development and Xenobiotic Metabolism; Eds: Mackness, B., Mackness, M., Aviram, M., Paragh, G. pp 251-266 Springer, 2007 | I. Seres, T. Fulop, G. Paragh, A.Khalil: AGE-RELATED ALTERATIONS IN PON1, in: The Paraoxonases: Their Role in Disease Development and Xenobiotic Metabolism; Eds: Mackness, B., Mackness, M., Aviram, M., Paragh, G. pp 199-206 Springer, 2007 | György Paragh, Ildikó Seres, Zsuzsa Varga, Gabriella Fóris: The concentration-dependent biphasic effect of leptin on the cholesterol biosynthesis in human monocytes, Absztrakt #T3:PO.115 Int J Obesity Vol 31. Suppl.1; p. S74, 2007 | Paragh G: THE HUMAN PARAOXONASE-1 PHENOTYPE MODIFIES THE EFFECT OF STATINS ON PON1 ACTIVITY AND LIPID PARAMETERS, 3rd International Conference on Paraoxonases, 2008 | Peter Koncsos, I. Seres, L. Józsa, I. Ilyés, F. Gönczi, E. Varga, G. Paragh: Different adipokine levels and paraoxonase activity in childhood obesity, Absztrakt #T3:PO.225 Int J Obesity Vol 31. Suppl.1; p. S160, 2007, 2007 | Mirdamadi HZ, Sztanek F, Derdak Z, Seres I, Harangi M, Paragh G.: The human paraoxonase-1 phenotype modifies the effect of statins on paraoxonase activity and lipid parameters., Br J Clin Pharmacol. 66(3):366-74., 2008 | Bajnok L, Seres I, Varga Z, Jeges S, Peti A, Karanyi Z, Juhasz A, Csongradi E, Mezosi E, Nagy EV, Paragh G.: Relationship of serum resistin level to traits of metabolic syndrome and serum paraoxonase 1 activity in a population with a broad range of body mass index., Exp Clin Endocrinol Diabetes 116(10):592-9, 2008 | Koncsos, P, Seres, I, Józsa, L, Ilyés, I, Gönczi, F, Sztanek, F, Harangi, M, Paragh, Gy: Effect of lifestyle changes in childhood obesity – changes in paraoxonase activity and adipokine levels, INTERNATIONAL JOURNAL OF OBESITY (32 )S123-S123 Suppl. 1 2008, 2008 | Paragh Gy Sztanek F, Koncsos P, Pados Gy, Audikovszky M., Varga É, Seres I: EFFECT OF LOW-FAT AND LOW-CARBOHYDRATE DIETS ON WEIGHT LOSS AND METABOLIC PARAMETERS, INTERNATIONAL JOURNAL OF OBESITY (32) S158-S158 Suppl. 1 2008, 2008 | Seres I: ALTERATION OF PON1 ACTIVITY IN OBESITY AND ITS RELATION TO ADIPOKINE LEVELS, 3rd International Conference on Paraoxonases, 2008 | I Seres, P Koncsos, F Sztanek, E Varga, G Paragh: ALTERATION OF PARAOXONASE-1 ACTIVITY IN CHILDHOOD OBESITY AND ITS RELATION TO ADIPOKINE LEVELS, Atherosclerosis Supplement 2009, Vol. 10, Issue 2; P1198, 2009 | F Sztanek, I Seres, L Locsey, B Szlanka, B Borbas, G Paragh: INFLUENCE OF BODY WEIGHT ON ADIPOKINES, SERUM PARAOXONASE, Atherosclerosis Supplement 2009, Vol. 10, Issue 2 P1193, 2009 | G Paragh, H Mirdamadi, M Harangi, F Sztanek, Z Derdak, A Kassai, I Seres: THE HUMAN PARAOXONASE-1 (PON1) PHENOTYPE MODIFIES THE EFFECT OF STATINS ON PON1 ACTIVITY AND LIPID PARAMETERS, Atherosclerosis Supplement 2009, Vol. 10, Issue 2; P1439, 2009 | M Harangi, H.Z. Mirdamadi, I.Seres, F.Sztanek, M.Molnár, A.Kassai, Z. Derdák, L.Illyés, Gy.Paragh:: Atorvastatin effect on the distribution of high-density lipoprotein subfractions and human paraoxonase activity., Translation Research 153;4:190-198, 2009 |
![](img/space.gif)
|
|
|
![](img/shadow_right_up.gif)
|
![](img/shadow_left_bottom.gif)
|
![](img/shadow_right_bottom.gif)
|
![](img/space.gif)
Back »
|
![](img/space.gif) |
|